Alembic Pharmaceuticals Limited has informed the Exchange that Mr. Chirayu Amin has Relinquished the position of Chief Executive Officer of the company w.e.f. April 01, 2026.
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mr. Chirayu Amin has relinquished the position of Chief Executive Officer (CEO) of Alembic Pharmaceuticals effective April 1, 2026, upon completion of his former tenure as Chairman & CEO on March 31, 2026. Simultaneously, shareholders at the 15th AGM held on August 5, 2025 approved his appointment as Executive Chairman for a period of 5 years, effective the same date. This represents a leadership restructuring where the combined Chairman & CEO role is being split into separate positions. Mr. Chirayu Amin is the father of Mr. Pranav Amin and Mr. Shaunak Amin, who serve as Managing Directors of the Company.
This is an internal leadership transition rather than an exit. Shareholders should note the separation of chairman and CEO roles, which may improve governance. The company's day-to-day operations will now be managed by a new CEO (not mentioned in this filing), while Chirayu Amin continues as Executive Chairman.